ACTRN12617000331336招募中2 期
A Phase 2 study of safety of Rivaroxaban compared with Low Molecular Weight Heparin (LMWH) for acute therapy of cancer-associated venous thromboembolism
South East Sydney and Illawarra Area Health Service0 个研究点目标入组 600 人开始时间: 2017年3月2日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 —（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Efficiency of rivaroxaban and enoxaparin in the prevention of venous thromboembolic eventsSpinal fusion.Osseous stenosis of neural canalM99.3IRCT20120527009878N16Tabriz University of Medical Sciences60
招募中
2 期
Evaluating the efficacy and safety of rivaroxaban comparing to warfarin in patients with chronic thromboembolic pulmonary hypertension (CTEPH) following endartrectomy surgeryChronic Thrombo Embolic Pulmonary Hypertension(CTEPH).Chronic Thromboembolic Pulmonary Hypertension.I27. 24IRCT20151227025726N22Shahid Beheshti University of Medical Sciences96
招募中
3 期
the effect of rivaroxaban on the prevention of deep vein thrombosis in nephrotic syndromephrotic syndrom.Nephrotic syndromeIRCT20220422054617N1Shiraz University of Medical Sciences20
进行中（未招募）
1 期
Proof of concept, multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS)Treatment of livedoid vasculopathyEUCTR2012-000108-13-DEniversitätsklinikum Münster28
已完成
2 期
A phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS)livedoid vasculopathyL95.0Livedoid vasculitisDRKS00004652niversitätsklinikum Münster28